Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NBT Bancorp (NBTB)

NBT Bancorp appoints Kimberly Boynton to board, expanding it to 13 directors

Neutral Impact 2 of 5 leadership Written later

NBT Bancorp's board increased its size to thirteen directors and appointed Kimberly A. Boynton, former President and CEO of Crouse Health, to fill the new seat effective October 1, 2026. The filing describes this as a board addition with no financial measures, and it does not change reported results.

Key points

  • Board expanded to thirteen directors; Boynton fills the newly created vacancy effective October 1, 2026.
  • Boynton, age 57, was President and CEO of Crouse Health from January 2014 until March 2023.
  • She is expected to serve on the Audit, Compensation and Benefits, and Risk Management Committees.
  • She will receive a prorated annual restricted stock unit grant and prorated annual retainers.

The filing

CompanyNBT Bancorp (NBTB)
Form8-K, current report
Filed with the SECSep 21, 2026, 4:15 PM ET
Accession number0001140361-26-037240

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.